Cetera Investment Advisers Journey Medical Corp Transaction History
Cetera Investment Advisers
- $55.9 Billion
- Q2 2025
A detailed history of Cetera Investment Advisers transactions in Journey Medical Corp stock. As of the latest transaction made, Cetera Investment Advisers holds 10,731 shares of DERM stock, worth $96,579. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,731
Previous 15,149
29.16%
Holding current value
$96,579
Previous $89,000
13.48%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding DERM
# of Institutions
62Shares Held
7.1MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA1.85MShares$16.7 Million0.8% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.15MShares$10.4 Million0.04% of portfolio
-
B. Riley Securities, Inc. Los Angeles, CA865KShares$7.78 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA565KShares$5.08 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA354KShares$3.19 Million0.44% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $104M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...